CENCORA, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
CENCORA, INC. (COR) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$316.65 million for the 9-month period ending 2025-06-30, per its 10-Q filed 2025-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2025-08-06
- CENCORA, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-06-30 was $172.82M, a 17.34% increase year-over-year.
- CENCORA, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-03-31 was -$151.34M, a 3523.98% decline year-over-year.
- CENCORA, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2024-12-31 was -$338.13M.
- CENCORA, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2024-06-30 was $147.28M, a 52.40% increase year-over-year.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month as first filed |
|---|---|---|---|---|
| 2025-06-30 | $172.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-06 | $21.48M derived: sum of 2 quarters · filed 2025-08-06 | -$316.65M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | -$151.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-07 | -$489.47M 10-Q · filed 2025-05-07 | ||
| 2024-12-31 | -$338.13M 10-Q · filed 2025-02-05 | |||
| 2024-06-30 | $147.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-06 | $151.70M derived: sum of 2 quarters · filed 2025-08-06 | -$87.27M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-07 | -$234.55M 10-Q · filed 2025-05-07 | ||
| 2023-12-31 | -$238.97M 10-Q · filed 2025-02-05 | |||
| 2023-06-30 | $96.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-31 | $69.98M derived: sum of 2 quarters · filed 2024-07-31 | -$163.66M 10-Q · filed 2024-07-31 | |
| 2023-03-31 | -$26.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-01 | -$260.30M 10-Q · filed 2024-05-01 | ||
| 2022-12-31 | -$233.64M 10-Q · filed 2024-01-31 | |||
| 2022-06-30 | -$134.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-02 | $45.79M derived: sum of 2 quarters · filed 2023-08-02 | -$268.94M 10-Q · filed 2023-08-02 | -$445.94M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $180.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-02 | -$134.66M 10-Q · filed 2023-05-02 | ||
| 2021-12-31 | -$314.73M 10-Q · filed 2023-02-01 | |||
| 2021-06-30 | $24.55M 10-Q · filed 2022-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |